We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$74.4B
AUM Growth
+$7.26B
Cap. Flow
+$2.46B
Cap. Flow %
3.31%
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,536
Reduced
421
Closed
97

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$141M
2
AAPL icon
Apple
AAPL
+$117M
3
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$96.6M
4
AMZN icon
Amazon
AMZN
+$63.7M
5
PLD icon
Prologis
PLD
+$47.7M

Sector Composition

Rank Sector Weight
1 Technology 22.05%
2 Healthcare 14.94%
3 Financials 14.18%
4 Consumer Discretionary 10%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MO icon
101
Altria Group
MO
$114B
$142M 0.19%
3,108,141
+127,174
+4% +$5.76M
APD icon
102
Air Products & Chemicals
APD
$65.6B
$140M 0.19%
455,673
+18,874
+4% +$5.32M
DUK icon
103
Duke Energy
DUK
$96.9B
$139M 0.19%
1,348,082
+48,568
+4% +$4.66M
SLB icon
104
SLB Ltd
SLB
$75.4B
$138M 0.19%
2,576,754
+101,707
+4% +$5.06M
NOW icon
105
ServiceNow
NOW
$122B
$137M 0.18%
1,768,280
+62,805
+4% +$4.91M
HUM icon
106
Humana
HUM
$43.5B
$137M 0.18%
267,117
+7,682
+3% +$4.04M
REGN icon
107
Regeneron Pharmaceuticals
REGN
$78.3B
$136M 0.18%
187,905
+8,907
+5% +$6.57M
BSX icon
108
Boston Scientific
BSX
$71.1B
$135M 0.18%
2,925,173
+194,639
+7% +$8.43M
ITW icon
109
Illinois Tool Works
ITW
$84.9B
$131M 0.18%
592,836
+18,160
+3% +$3.87M
CL icon
110
Colgate-Palmolive
CL
$73.8B
$130M 0.17%
1,646,678
+58,161
+4% +$4.36M
CSX icon
111
CSX Corp
CSX
$94.5B
$127M 0.17%
4,097,428
+115,447
+3% +$3.47M
BDX icon
112
Becton Dickinson
BDX
$46.9B
$124M 0.17%
488,469
+19,192
+4% +$4.53M
VRTX icon
113
Vertex Pharmaceuticals
VRTX
$121B
$123M 0.17%
426,737
+18,554
+5% +$5.65M
PNC icon
114
PNC Financial Services
PNC
$101B
$123M 0.16%
776,405
+17,710
+2% +$2.79M
WM icon
115
Waste Management
WM
$90B
$122M 0.16%
779,669
+23,015
+3% +$3.7M
EQIX icon
116
Equinix
EQIX
$104B
$122M 0.16%
186,302
+8,130
+5% +$5.02M
EMR icon
117
Emerson Electric
EMR
$89B
$122M 0.16%
1,270,285
+63,485
+5% +$5.71M
GD icon
118
General Dynamics
GD
$104B
$122M 0.16%
490,695
+14,688
+3% +$3.58M
ETN icon
119
Eaton
ETN
$173B
$119M 0.16%
760,322
+48,874
+7% +$7.49M
FISV
120
Fiserv Inc
FISV
$29.7B
$118M 0.16%
1,172,073
+39,941
+4% +$3.98M
CME icon
121
CME Group
CME
$94.4B
$117M 0.16%
698,481
+26,002
+4% +$4.52M
CCI icon
122
Crown Castle
CCI
$33.9B
$117M 0.16%
863,063
+31,596
+4% +$4.27M
MCK icon
123
McKesson
MCK
$97.2B
$117M 0.16%
312,035
+10,762
+4% +$4.01M
DG icon
124
Dollar General
DG
$28.1B
$115M 0.15%
467,253
+15,454
+3% +$3.82M
NSC icon
125
Norfolk Southern
NSC
$76.7B
$115M 0.15%
465,965
+21,559
+5% +$5.1M

Similar funds

RhumbLine Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,536 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.

  • RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
  • RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
  • RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
  • RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
  • RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
  • RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.